LOS ANGELES – Broadcast television may be littered with mockumentaries but that doesn’t mean there isn’t room for one more. “What someone told me early on is it doesn’t matter if five people are doing ...
Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for ...
Canaccord raised the firm’s price target on Mind Medicine (MNMD) to $16 from $14 and keeps a Buy rating on the shares. The firm said they ...
This year, Tailbone Pain Awareness Day falls on Nov. 13, and to mark the occasion, Foye will host a Facebook Live session at ...
As a medical services officer with the New Jersey Army National Guard, 1st Lt. Rachel Cary, MD ’25, is focused on maintaining ...
Researchers today (Nov. 8, 2024) are releasing the flagship dataset from an ambitious study of biomarkers and environmental factors that might influence the development of type 2 diabetes.
Main Line Health, the first to report last week, showed positive momentum continuing. The four-hospital system narrowed its quarterly loss to $3.6 million from $27.8 million. That was after slashing ...
The buzz of excitement could be felt radiating throughout the Centre Core at Lethbridge Polytechnic from students and faculty alike as the institution unveiled its new logo earlier this week.
-- On-track to initiate IND-enabling activities for Wilson’s Disease program in 4Q 2024, with IND or CTA filing expected in 1H 2026 -- CAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) ...
The National Academy of Medicine has elected 100 new members, including eight from the Philadelphia area. Their expertise ranges from cardiovascular to community health. The National Academy of ...
Watch Married to Medicine premiering November 24 on Bravo. Now streaming on Peacock and the Bravo App. You don't have to take our word for it, though. With the Oct. 21 announcement of the Bravo ...
CAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic ...